BioNTech SE - ADR vs iShares 7-10 Year Treasury Bond ETF — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while iShares 7-10 Year Treasury Bond ETF trades at $93.12. The key difference: BioNTech SE - ADR is trading nearer its 52-week high, iShares 7-10 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| BNTX | IEF | |
|---|---|---|
Market Cap | $23.31B | — |
Sector | Health | — |
52-Week High | $119.34 | $97.99 |
52-Week Low | $83.89 | $92.76 |
Enterprise Value | $6.60B | — |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.
Read more on IEF →